Amber List

ABTAbbott Laboratories

Healthcare · Medical Devices · large-cap ($151.6B)
-36.7%
from rolling 252-day high of $136.28 set 2025-06-24 · 338d ago
Current
$86.30
Decline depth
-36.7%
Decline σ
4.3σ
TFC
4/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Since it joined the list

$ABT landed on the list 2026-03-08, down 19.0% from its 52-week high that day — now down -36.7%.

That's 13.4 percentage points deeper than the day it joined. It bottomed 40.7% below that high along the way.

Decline from the 52-week high as it stood on 2026-03-09 (fixed anchor) → today. Split-adjusted, Alpaca. Observed history, not a forecast.

Structural break signals

ABT qualifies for the Amber List on decline depth.

Decline depth
-36.7%
From rolling 252-day high of $136.28, 338d ago. Past the 30% Amber threshold.
Time-frame continuity
4/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3. Past the 4/5 Amber threshold.
Decline sigma
4.3σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (1.61% per day). Past the ≥4σ Watch threshold.

The structural read

What price action says about ABT.

ABT qualifies for the Amber List on decline depth — down -36.7% from its rolling 252-day high.

Cross-confirmation: also showing 4/5 bearish time frames.

Cross-confirmation: decline sigma also reads 4.3σ over 20 bars.

Upstream TFC read: weak alignment, current phase daily. Last bar types — daily 1 (green), weekly 1 (red), monthly 2D (red).

Earnings on file: 2026-04-16. Tiering is unaffected by earnings dates — listings reflect price structure only.

52-week range

52W low $86.15 0.3% of range 52W high $139.06

Sector context · Healthcare

194 other Healthcare tickers are on Broken Stocks.

89 Red List
46 Amber
59 Watch
-35.8% Median decline

Worst in sector: OPRX (-77.1%). Least-bad: MRNA (-20.1%). See all Healthcare listings →

Questions about ABT

What people ask.

Why is ABT on Broken Stocks?

ABT qualifies for the Amber List on decline depth. It is down -36.7% from its rolling 252-day high of $136.28, set on 2025-06-24 — 338d ago.

Is ABT a falling knife?

Not by the strict technical definition. ABT is down -36.7% from its 52-week high, but that high was set 338d ago — more than 120 days. A falling knife is usually a recent breakdown from a fresh high, not an established multi-quarter downtrend. ABT is still on the Amber List for decline depth, but the freshness component of a falling knife is missing.

Is ABT a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is ABT trading inside its 52-week range?

At $86.30, ABT sits 0.3% of the way from its 52-week low ($86.15) to its 52-week high ($139.06). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has ABT been declining?

The current 36.7% decline accrued over 338d, which annualizes to roughly -39.6% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does ABT compare to its sector?

There are 194 other Healthcare tickers on Broken Stocks: 89 Red, 46 Amber, 59 Watch, with 108 showing recovering structural signals. Median sector decline is -35.8% — ABT's decline is deeper than the sector median.

Does ABT's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-04-16) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.